News|Articles|January 7, 2026

FDA Activity Recap: December 2025 Features Multiple Approvals, RMAT Designation, and More

Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.

Last month, December 2025, the CGTLive^® team was diligently tracking the FDA's activities related to the development of cell and gene therapies for the treatment of rare, complex, and otherwise challenging diseases and disorders.